Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
On April 1, 2026, the FDA approved Eli Lillys FOUNDAYO (orforglipron) , the second oral GLP-1 approved for obesity, and arguably the one with the more patient-friendly convenience profile
Laboratory research record on GLP-1S [PMID: 40466245] PubMed laboratory record discussing GLP-1S in a research context
If prescribed, the Noom Microdose GLP-1 Rx Programs start at $49 and include medication, home delivery, 24/7 messaging with your care team, personalized coaching, and habit-building tools to help you stay on track
This is not medical advice, diagnosis, or treatment.
US$ 25.43
US$ 21.95
US$ 26.33
US$ 29.55
US$ 24.29
US$ 23.94
US$ 28.91
